Testing MR and yellow fever vaccines together in babies
Treatments studied
Part of Infections clinical trials.
This trial checks whether giving the measles-rubella (MR) and yellow fever vaccines at the same time is safe and works well in healthy babies aged 9 to 12 months. It may help simplify the vaccination schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is 9 to 12 months old
- Your baby is generally healthy, with no serious medical conditions
- Your baby has never had the measles, rubella, or yellow fever vaccine
- Your baby has not been around someone with measles, rubella, or yellow fever in the last month
- Your baby does not have an allergy to eggs, chicken, or neomycin
- Your baby has no history of certain infections like dengue or Japanese encephalitis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined vaccine that protects against measles, mumps, rubella, and chickenpox (varicella) in one shot. It's for healthy children who have already had their first dose of chickenpox and MMR vaccines, to see if this booster is safe and works well.
This trial studies how well the yellow fever vaccine “17D” stimulates the immune system (the body’s germ-fighting response) in adults who were vaccinated with 17D years ago. It may help researchers understand whether a prior vaccination still provides protection and how strong the immune response is.
This study tests a combined booster vaccine for measles, mumps, rubella, and chickenpox in healthy children aged 4 to 6. It aims to see how well the vaccine boosts the immune system and if it is safe.
This trial tests a new yellow fever vaccine in young children. It will see if the vaccine is safe and produces a good immune response, including when given with the MMR vaccine.
This trial is testing whether giving the R21 malaria vaccine to infants at different ages (starting at 2 months or 3 months) works as well as starting at 6 weeks. It will help find the best schedule to protect babies against malaria.
This study tests whether changing the measles vaccine timing in 6-month-old children can reduce allergy risk and also help protect against unrelated infections. If your child is already up to date with routine vaccines, they may be eligible for a modified measles (MMR) schedule used in the trial.
Hear when a new Measles trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.